News | ReviveMed

News

ReviveMed Presented at ASCO 2024 "Examining Response to Immunotherapy in Clear-Cell Renal Cell Carcinoma Using Baseline Serum Metabolic Signatures"

ReviveMed Announces AI-driven Metabolomics Study with Bristol Myers Squibb

ReviveMed CEO selected as a 35 under 35 innovator by the MIT Technology review

ReviveMed Receives Frost & Sullivan AI-Driven Next-Generation Metabolomics Technology Innovation Award

ReviveMed CEO Dr. Pirhaji to present at TED2019, joining the newest class of 20 global visionaries

ReviveMed received a 2nd LabCentral Golden Ticket Award from Bristol-Meyers Squibb

ReviveMed turns drug discovery into a big data problem and raises $1.5M to solve it

ReviveMed received the Novartis & LabCentral Golden Ticket Award, sponsoring our lab space

ReviveMed Inc. | info@revivemed.io | copyright ©2024